You are viewing: North America Gastrointestinal Products Market analysis

The North America Gastrointestinal Products Market was valued at $5720 Million in 2024 and projected to reach to $7826.3 Million by 2029, representing a compound annual growth rate of 6.5%. North America's gastrointestinal products market is positioned for sustained expansion through 2029, supported by rising incidence of GI disorders, increased consumer awareness, and continuous innovation in treatment modalities.

North America Gastrointestinal Products Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Gastrointestinal Products Market Trends and Insights

  • In North America, the market is driven by rising prevalence of gastrointestinal disorders, aging demographics, and increased healthcare spending.
  • North America maintains a strong position in the global market due to advanced healthcare infrastructure, high adoption of innovative treatments, and robust reimbursement frameworks that support product accessibility. The forecast period from 2024 to 2029 reflects North America's continued investment in digestive health solutions and preventive care initiatives.
  • North America's market growth is supported by increasing consumer awareness, expanding product portfolios from leading manufacturers, and growing demand for over-the-counter and prescription gastrointestinal medications.
  • North America is expected to remain a key revenue contributor to the global gastrointestinal products market throughout the forecast period..

Key Market Statistics

  • CAGR (2024-2029) 6.5% CAGR
  • Market Size, 2024 ~USD 5720 Million
  • Forecast, 2029 ~USD 7826.3 Million
  • Geography North America

North America Gastrointestinal Products Market Overview

Market Valuation & Growth :

North America's gastrointestinal products market reached $5,720 million in 2024 and is projected to expand to $7,826.3 million by 2029, driven by a robust 6.5% CAGR, outpacing the global growth rate of 6.1%.

Aging Population Dynamics :

North America's aging demographic profile significantly drives demand for gastrointestinal products, as older populations experience higher prevalence of digestive disorders, acid reflux, and inflammatory bowel conditions requiring ongoing treatment.

Healthcare Spending Leadership :

The region benefits from elevated healthcare expenditure and strong insurance coverage, enabling widespread adoption of advanced gastrointestinal therapeutics, diagnostic tools, and over-the-counter remedies across both clinical and consumer segments.

US Market Dominance :

The United States represents the largest market within North America at $3,663.9 million, accounting for approximately 64% of the regional market, with Canada contributing $458.4 million to the overall regional growth trajectory.

North America Gastrointestinal Products Market Dynamics

  • The region's mature healthcare infrastructure, coupled with strong pharmaceutical R&D capabilities, enables rapid adoption of novel therapies and digital health solutions for gastrointestinal management. Key growth drivers include an aging population requiring chronic disease management, expanding over-the-counter product portfolios, and growing investment in preventive gastroenterology.
  • Market consolidation among major players and strategic partnerships will further enhance market penetration, while regulatory support for new drug approvals ensures a steady pipeline of innovative solutions addressing unmet clinical needs in North America..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • North America's gastrointestinal products market is valued at $5,720 million in 2024 and will reach $7,826.3 million by 2029 with a 6.5% CAGR.
    • North America benefits from advanced healthcare infrastructure, high treatment adoption rates, and strong reimbursement policies that drive market expansion.
    • Rising gastrointestinal disorder prevalence and an aging population are key growth drivers for North America's market through 2029.
    • North America maintains a leading position in the global gastrointestinal products market due to innovation, consumer awareness, and diverse product offerings.

    Gastrointestinal Products Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment IRRITABLE BOWEL SYNDROME (IBS) (Disease)
    Forecast Period 2024-2029
    Growth Rate CAGR of 6.1% from 2024 to 2029
    Largest Segment ENDOSCOPY DEVICES (Device)
    Market Size Base Year (Billions) ~USD 14.65 (2024)
    Revenue Forecast (Billions) ~USD 19.7 (2029)
    Segments Covered Device, Type, Disease, End User

    North America Gastrointestinal Products Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device

    • Ablation Devices
    • Biopsy Devices
    • Endoscopy Devices
    • Motility Testing Devices
    • Other Gastroenterology/ Gastrointestinal Devices
    • Other Gastroenterology/Gastrointestinal Devices
    • Ph Monitoring Devices
    • Stenting Devices

    By Type

    • 4-Hour Ph Impedance Testing Devices
    • Ambulatory Ph Monitoring Systems
    • Anorectal Manometry Devices
    • Biliary Stents
    • Capsule Endoscopes
    • Colonic Stents
    • Cryoablation Devices
    • Duodenal Stents
    • Esophageal Manometry Devices
    • Esophageal Ph Monitoring Catheters
    • Esophageal Stents
    • Flexible Endoscopes
    • Gastric Balloons
    • Gastrointestinal Tubes
    • Hemorrhoid Treatment Devices
    • Laser Ablation Devices
    • Microwave Ablation Devices
    • Needle Biopsy Devices
    • Other Ablation Devices
    • Other Biopsy Devices
    • Other Endoscopy Devices
    • Other Motility Testing Devices
    • Pancreatic Stents
    • Radiofrequency Ablation Devices
    • Rigid Endoscopes
    • Wireless Ph Monitoring Capsules

    By Disease

    • Gastroesophageal Reflux Disease (Gerd)
    • Gastrointestinal Cancers
    • Inflammatory Bowel Disease (Ibd)
    • Irritable Bowel Syndrome (Ibs)
    • Other Diseases

    By End User

    • Ambulatory Surgical Centers & Independent Diagnostic Centers
    • Clinics
    • Hospitals
    • Other End Users

    Target Audience

    • Pharmaceutical Manufacturers : Require detailed North American market data to guide R&D investments, clinical trial planning, and commercialization strategies for gastrointestinal drug products in this high-value region.
    • Medical Device Companies : Need regional market insights to develop and launch diagnostic and therapeutic GI devices, understand reimbursement landscapes, and identify partnership opportunities with healthcare providers.
    • Healthcare Investors & PE Firms : Seek comprehensive North American market analysis to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in the gastrointestinal sector.
    • Healthcare Consultants & Advisors : Utilize regional market data to provide evidence-based strategic recommendations to clients, support due diligence processes, and develop market entry or expansion strategies.
    • OTC & Nutraceutical Companies : Need North American market intelligence to understand consumer demand trends, competitive positioning, and distribution channel opportunities for digestive health and wellness products.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 5438 Million · 5.7% wtd CAGR ·
    Asia Pacific
    ~USD 5661.7 Million · 6.1% wtd CAGR ·
    Latin America
    ~USD 521.2 Million · 4.5% wtd CAGR ·
    Middle East & Africa
    ~USD 277.9 Million · 5% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 3663.9 Million
    CanadaUSD 458.4 Million

    Country market size visualization

    US
    USD 3663.9 Million
    Canada
    USD 458.4 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into North America's gastrointestinal market with country-level breakdowns for the US and Canada, enabling precise market targeting and localized business strategy development.
    • Growth Trajectory Analysis : Understand the 6.5% CAGR growth dynamics specific to North America, outperforming global benchmarks, to identify expansion opportunities and optimize resource allocation across the region.
    • Demographic & Healthcare Insights : Access comprehensive analysis of aging population trends and healthcare spending patterns driving North American demand, essential for product positioning and market entry strategies.
    • Competitive Landscape Intelligence : Benchmark your organization against regional market leaders and understand the competitive dynamics unique to North America's mature healthcare ecosystem and regulatory environment.
    • Forecast-Driven Decision Making : Leverage 2029 market projections ($7.83B) to inform long-term strategic planning, investment decisions, and product development roadmaps tailored to North American market evolution.

    Frequently asked questions

    What is the current size of North America's gastrointestinal products market?

    North America's gastrointestinal products market was valued at $5,720 million in 2024.

    What is the projected market size for North America by 2029?

    North America's gastrointestinal products market is projected to reach $7,826.3 million by 2029.

    What is the CAGR for North America's gastrointestinal products market?

    North America's gastrointestinal products market is expected to grow at a compound annual growth rate of 6.5% from 2024 to 2029.

    What factors are driving growth in North America's gastrointestinal products market?

    North America's market growth is driven by rising gastrointestinal disorder prevalence, aging demographics, advanced healthcare infrastructure, increased consumer awareness, and strong reimbursement frameworks.

    Why is North America significant in the global gastrointestinal products market?

    North America is significant due to its advanced healthcare systems, high product adoption rates, robust reimbursement policies, strong innovation pipelines, and substantial healthcare spending on digestive health solutions.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

    Gastroenterology Products Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.

    Country-Level Analysis

    The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region & Country)

    • Approach 1:
      • Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends.
    • Approach 2:
      • Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews).

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    To know about the assumptions considered for the study, Request for Free Sample Report

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.

    Market Definition

    Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.

    Key Stakeholders

    • Medical Device Manufacturers
    • Healthcare Institutions (hospitals and outpatient clinics)
    • Distributors and Suppliers
    • Research Institutes
    • Health Insurance Payers
    • Market Research and Consulting Firms

    Report Objectives

    • To define, describe, segment, and forecast the global gastrointestinal Products Market by devices, diseases end users, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall gastrointestinal products market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the gastroenterology products market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global gastrointestinal products market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the gastrointestinal products market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Geographic Analysis

    • Further breakdown of the Latin American apheresis into specific countries and, the Middle East, and Africa apheresis into specific countries and further breakdown of the European apheresis into specific countries

    Get the Full Gastrointestinal Products Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status